178 related articles for article (PubMed ID: 31961651)
1. A Versatile Chemoenzymatic Synthesis for the Discovery of Potent Cryptophycin Analogs.
Schmidt JJ; Khatri Y; Brody SI; Zhu C; Pietraszkiewicz H; Valeriote FA; Sherman DH
ACS Chem Biol; 2020 Feb; 15(2):524-532. PubMed ID: 31961651
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the cryptophycin P450 epoxidase reveals substrate tolerance and cooperativity.
Ding Y; Seufert WH; Beck ZQ; Sherman DH
J Am Chem Soc; 2008 Apr; 130(16):5492-8. PubMed ID: 18366166
[TBL] [Abstract][Full Text] [Related]
3. Chemoenzymatic synthesis of cryptophycin/arenastatin natural products.
Beck ZQ; Aldrich CC; Magarvey NA; Georg GI; Sherman DH
Biochemistry; 2005 Oct; 44(41):13457-66. PubMed ID: 16216069
[TBL] [Abstract][Full Text] [Related]
4. Biosynthetic characterization and chemoenzymatic assembly of the cryptophycins. Potent anticancer agents from cyanobionts.
Magarvey NA; Beck ZQ; Golakoti T; Ding Y; Huber U; Hemscheidt TK; Abelson D; Moore RE; Sherman DH
ACS Chem Biol; 2006 Dec; 1(12):766-79. PubMed ID: 17240975
[TBL] [Abstract][Full Text] [Related]
5. Cryptophycins-309, 249 and other cryptophycin analogs: preclinical efficacy studies with mouse and human tumors.
Liang J; Moore RE; Moher ED; Munroe JE; Al-awar RS; Hay DA; Varie DL; Zhang TY; Aikins JA; Martinelli MJ; Shih C; Ray JE; Gibson LL; Vasudevan V; Polin L; White K; Kushner J; Simpson C; Pugh S; Corbett TH
Invest New Drugs; 2005 Jun; 23(3):213-24. PubMed ID: 15868377
[TBL] [Abstract][Full Text] [Related]
6. Efficient synthesis of cryptophycin-52 and novel para-alkoxymethyl unit A analogues.
Eissler S; Bogner T; Nahrwold M; Sewald N
Chemistry; 2009 Oct; 15(42):11273-87. PubMed ID: 19760734
[TBL] [Abstract][Full Text] [Related]
7. Chemoenzymatic synthesis of cryptophycin anticancer agents by an ester bond-forming non-ribosomal peptide synthetase module.
Ding Y; Rath CM; Bolduc KL; Håkansson K; Sherman DH
J Am Chem Soc; 2011 Sep; 133(37):14492-5. PubMed ID: 21823639
[TBL] [Abstract][Full Text] [Related]
8. Efficient and versatile stereoselective synthesis of cryptophycins.
Mast CA; Eissler S; Stoncius A; Stammler HG; Neumann B; Sewald N
Chemistry; 2005 Aug; 11(16):4667-77. PubMed ID: 15915529
[TBL] [Abstract][Full Text] [Related]
9. Cryptophycins: a novel class of potent antimitotic antitumor depsipeptides.
Shih C; Teicher BA
Curr Pharm Des; 2001 Sep; 7(13):1259-76. PubMed ID: 11472266
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of a new class of cryptophycins based tubulin inhibitors.
Kumar A; Kumar M; Sharma S; Guru SK; Bhushan S; Shah BA
Eur J Med Chem; 2015 Mar; 93():55-63. PubMed ID: 25647428
[TBL] [Abstract][Full Text] [Related]
11. Thioesterases as tools for chemoenzymatic synthesis of macrolactones.
Paquette AR; Brazeau-Henrie JT; Boddy CN
Chem Commun (Camb); 2024 Mar; 60(25):3379-3388. PubMed ID: 38456624
[TBL] [Abstract][Full Text] [Related]
12. Approaches for the synthesis of functionalized cryptophycins.
Sammet B; Bogner T; Nahrwold M; Weiss C; Sewald N
J Org Chem; 2010 Oct; 75(20):6953-60. PubMed ID: 20857920
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of cryptophycin analogs with substitution at C-6 (fragment C region).
Varie DL; Shih C; Hay DA; Andis SL; Corbett TH; Gossett LS; Janisse SK; Martinelli MJ; Moher ED; Schultz RM; Toth JE
Bioorg Med Chem Lett; 1999 Feb; 9(3):369-74. PubMed ID: 10091686
[TBL] [Abstract][Full Text] [Related]
14. Recent approaches for the synthesis of modified cryptophycins.
Weiss C; Sammet B; Sewald N
Nat Prod Rep; 2013 Jul; 30(7):924-40. PubMed ID: 23732943
[TBL] [Abstract][Full Text] [Related]
15. Chemoenzymatic synthesis of the polyketide macrolactone 10-deoxymethynolide.
Aldrich CC; Venkatraman L; Sherman DH; Fecik RA
J Am Chem Soc; 2005 Jun; 127(25):8910-1. PubMed ID: 15969542
[TBL] [Abstract][Full Text] [Related]
16. Novel cryptophycin antitumor agents: synthesis and cytotoxicity of fragment "B" analogues.
Patel VF; Andis SL; Kennedy JH; Ray JE; Schultz RM
J Med Chem; 1999 Jul; 42(14):2588-603. PubMed ID: 10411479
[TBL] [Abstract][Full Text] [Related]
17. Three new cryptophycins from Nostoc sp. GSV 224.
Subbaraju GV; Golakoti T; Patterson GM; Moore RE
J Nat Prod; 1997 Mar; 60(3):302-5. PubMed ID: 9090872
[TBL] [Abstract][Full Text] [Related]
18. Cryptophycin-55/52 based antibody-drug conjugates: Synthesis, efficacy, and mode of action studies.
Lai Q; Wu M; Wang R; Lai W; Tao Y; Lu Y; Wang Y; Yu L; Zhang R; Peng Y; Jiang X; Fu Y; Wang X; Zhang Z; Guo C; Liao W; Zhang Y; Kang T; Chen H; Yao Y; Gou L; Yang J
Eur J Med Chem; 2020 Aug; 199():112364. PubMed ID: 32402935
[TBL] [Abstract][Full Text] [Related]
19. A convergent approach to cryptophycin 52 analogues: synthesis and biological evaluation of a novel series of fragment a epoxides and chlorohydrins.
Al-Awar RS; Ray JE; Schultz RM; Andis SL; Kennedy JH; Moore RE; Liang J; Golakoti T; Subbaraju GV; Corbett TH
J Med Chem; 2003 Jul; 46(14):2985-3007. PubMed ID: 12825938
[TBL] [Abstract][Full Text] [Related]
20. Biological evaluation of cryptophycin 52 fragment A analogues: effect of the multidrug resistance ATP binding cassette transporters on antitumor activity.
Al-Awar RS; Corbett TH; Ray JE; Polin L; Kennedy JH; Wagner MM; Williams DC
Mol Cancer Ther; 2004 Sep; 3(9):1061-7. PubMed ID: 15367700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
